|
|
Active Org.- |
|
Active Indication- |
|
Drug Highest PhasePending |
First Approval Ctry. / Loc.- |
First Approval Date20 Jan 1800 |
100 Clinical Results associated with PDGFR x VEGFR2 x PLK1
100 Translational Medicine associated with PDGFR x VEGFR2 x PLK1
0 Patents (Medical) associated with PDGFR x VEGFR2 x PLK1